Dr. Jason Sicklick

/Tag:Dr. Jason Sicklick

Population-based study of adolescent and young adult GIST patients

Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, MD, indicate that small intestine tumors in adolescents and young [...]

By | 2017-01-25T13:55:28+00:00 January 25th, 2017|News, Research|

Important research study holds hope for “Quadruple Wildtype” GIST patients

A recent study published in the Journal of Translational Medicine, presents important research findings for the 10-15% of GIST patients who lack mutations in KIT, PDGFRA, SDHX or RAS pathway indicators, the primary oncogenic drivers [...]

By | 2017-01-06T11:51:16+00:00 January 6th, 2017|News, Research|

Wild Type Track at Life Fest 2016 provided informative sessions

The following are summaries of two of the Wild Type GIST parallel track sessions at Life Fest, 2016, submitted by Rebecca Bensenhaver of GSI International.  "I was fortunate to be able to attend Life Fest [...]

By | 2016-08-19T12:21:24+00:00 August 19th, 2016|GIST Education, News|

Top GIST specialists present at California GDOL

On Sunday, November 15, the last GDOL in the 2015 series was held in Orange County, California at the Fullerton Arboretum. GDOL stands for GIST Day of Learning, a free, one-day program that provides both [...]

By | 2016-08-17T13:26:17+00:00 December 16th, 2015|Advocacy, GDOL, GIST Education, Newsletter|

Epidemiology of GIST: Interview with Dr. Jason Sicklick

In a recently published study, Jason Sicklick, MD, surgical oncologist at University of California, San Diego Health System, and his team of researchers published their findings on the epidemiology of GIST. His findings, which have [...]

By | 2014-12-08T17:19:13+00:00 December 8th, 2014|Diagnosis, GIST Education, News, Tissue Bank|

Recent Posts

Upcoming Events

  1. Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM